Skip links

Policy & Regulation

Providing Strategic Clarity in a Shifting Regulatory and Policy Environment

Healthcare innovation resides in an increasingly interconnected policy and regulatory environment. As AI, digital health, and life sciences continue to evolve, policy and regulation increasingly shape strategic decisions, innovation pathways, and organisational risk.

At Pamanicor Health, our expertise helps you understand policy and regulatory developments early, assess their strategic implications and translate them into cross-functional alignment and operational readiness in complex, highly regulated, and fast-moving environments.

We help you focus on what matters, when it matters, and how it may affect business decisions, innovation pathways, and long-term positioning.

Our solutions

Policy & Regulation

Policy and Regulation are about understanding how external frameworks, institutional priorities, and regulatory developments affect innovation, growth, and execution. Effective policy and regulatory strategy provide clarity on the external developments that matter most, and their implications for business, innovation, and market participation.

 

In today’s health and life sciences environment, organisations must navigate a complex landscape spanning AI, digital health, health data, market access, product requirements, and broader governance expectations. These developments are influenced not only by regulators, but also by policymakers, institutions, payers, and standard-setting bodies.

Our solutions

We support our clients to understand the practical implications of policy and regulatory change for risk, innovation, governance and execution.

Our approach is strategic, cross-disciplinary, and grounded in practical relevance.

EU AI Act Readiness

Understanding how the regulation of AI (EU AI Act) affects AI strategy, product governance, risk classification, documentation expectations, human oversight, and lifecycle compliance planning, especially where AI intersects with regulated health use cases.

EHDS, Data Governance and Digital Sovereignty

Implications of the European Health Data Space for health-data access, data-sharing models, secondary use, governance design, and organizational readiness. Including digital sovereignty and infrastructure choices that may affect partnerships, procurement, and operating models.

MDR, IVDR and Regulatory Pathways

Strategic guidance for software, digital health solutions, connected devices, clinical workflows, documentation requirements, and post-market obligations, with reference to current European guidance where relevant.

Evidence and Market Access Implications

Helping understand how policy and regulatory developments shape evidence requirements, access pathways, and implementation. Relevant where reimbursement, trust, adoption, and regulatory acceptability depend on credible evidence generation.

Policy Intelligence and Impact Assessment

Monitoring policy and regulatory developments, assessing their implications for products, portfolios, operating models, market access, evidence expectations, and broader business priorities to help you identify emerging opportunities.

Briefings and Decision Prioritisation

Providing focused briefings and senior-level insights to help prioritise relevant policy and regulation developments and their strategic implications across immediate, medium-term, and longer-range horizons.

Let’s get started

At Pamanicor Health we help you understand how policy direction and regulatory change translate into business relevance, so that you can act with greater confidence, focus, and foresight.

To discuss policy and regulatory developments affecting your organisation contact us.

Contact us